U

Ultragenyx Pharmaceutical Inc.

1424 employees

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Investor insights

Funding rounds participated in

$40M sweet spot round size

Most of their 1 investments are in rounds between $40M and $40M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
rare disease and ultra-rare disease
Pharmaceutical

Date founded

2010

Investments made

U

Undisclosed raised $40M on October 23, 2020

Investors: Ultragenyx Pharmaceutical Inc.

Funding rounds raised

Total raised

$75M

from 8 investors over 8 rounds

U

Ultragenyx Pharmaceutical Inc. raised $65M on June 7, 2016

Investors: Takeda UK Limited

U

Ultragenyx Pharmaceutical Inc. raised $75M on December 31, 2012

Investors: Adage Capital Management, F-Prime Capital Partners, Pappas Ventures and HealthCap

U

Ultragenyx Pharmaceutical Inc. raised $45M on June 20, 2011

Investors: HealthCap, Pappas Ventures and F-Prime Capital Partners

FAQ